These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15518603

  • 21. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.
    Ndrepepa G, Mehilli J, Schulz S, Iijima R, Keta D, Byrne RA, Pache J, Seyfarth M, Schömig A, Kastrati A.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):512-7. PubMed ID: 18687242
    [Abstract] [Full Text] [Related]

  • 22. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.
    Gibson CM, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E, TIMI Study Group.
    J Am Coll Cardiol; 2004 Sep 01; 44(5):980-7. PubMed ID: 15337207
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Grade 3 ischemia on the admission electrocardiogram predicts failure of ST resolution and of adequate flow restoration after primary percutaneous coronary intervention for acute myocardial infarction.
    Wolak A, Yaroslavtsev S, Amit G, Birnbaum Y, Cafri C, Atar S, Gilutz H, Ilia R, Zahger D.
    Am Heart J; 2007 Mar 01; 153(3):410-7. PubMed ID: 17307421
    [Abstract] [Full Text] [Related]

  • 26. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, Browne K, Iwaoka R, Azrin M, Stapleton D, Setum C, Popma J, AIMI Investigators.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):244-52. PubMed ID: 16843170
    [Abstract] [Full Text] [Related]

  • 27. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.
    Steinberg BA, Moghbeli N, Buros J, Ruda M, Parkhomenko A, Raju BS, García-Castillo A, Janion M, Nicolau JC, Fox KA, Morrow DA, Gibson CM, Antman EM.
    Am Heart J; 2007 Jul 18; 154(1):54-61. PubMed ID: 17584551
    [Abstract] [Full Text] [Related]

  • 28. Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging.
    Thiele H, Kappl MJ, Linke A, Erbs S, Boudriot E, Lembcke A, Kivelitz D, Schuler G.
    Eur Heart J; 2007 Jun 18; 28(12):1433-9. PubMed ID: 17556347
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study.
    De Luca G, Suryapranata H, Dambrink JH, Ottervanger JP, van 't Hof AW, Zijlstra F, Hoorntje JC, Gosselink AT, de Boer MJ.
    Am Heart J; 2004 Nov 18; 148(5):852-6. PubMed ID: 15523317
    [Abstract] [Full Text] [Related]

  • 33. The degree of restored myocardial perfusion in acute myocardial infarction influences immediate and long-term results of primary coronary angioplasty.
    Zmudka K, Zalewski J, Przewłocki T, Zajdel W, Czunko P, Durak M, Zorkun C, Podolec P, Tracz W.
    Kardiol Pol; 2004 Oct 18; 61(10):316-27; discussion 327-8. PubMed ID: 15841113
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.
    De Luca G, van 't Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Suryapranata H.
    Eur Heart J; 2005 Apr 18; 26(7):662-6. PubMed ID: 15681574
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, Spiewak M, Kochman J, Rudowski R, Opolski G.
    Int J Cardiol; 2007 Feb 14; 115(3):386-90. PubMed ID: 16860415
    [Abstract] [Full Text] [Related]

  • 39. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
    Fu XH, Hao QQ, Jia XW, Fan WZ, Gu XS, Wu WL, Hao GZ, Li SQ, Jiang YF, Geng W.
    Chin Med J (Engl); 2008 Mar 20; 121(6):522-7. PubMed ID: 18364139
    [Abstract] [Full Text] [Related]

  • 40. Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Alhadramy O, Westerhout CM, Brener SJ, Granger CB, Armstrong PW, APEX AMI Investigators.
    Am Heart J; 2010 May 20; 159(5):899-904. PubMed ID: 20435202
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.